Literature DB >> 10736175

A three-step kinetic mechanism for peptide binding to MHC class II proteins.

R V Joshi1, J A Zarutskie, L J Stern.   

Abstract

Peptide binding reactions of class II MHC proteins exhibit unusual kinetics, with extremely slow apparent rate constants for the overall association (<100 M(-)(1) s(-)(1)) and dissociation (<10(-)(5) s(-)(1)) processes. Various linear and branched pathways have been proposed to account for these data. Using fluorescence resonance energy transfer between tryptophan residues in the MHC peptide binding site and aminocoumarin-labeled peptides, we measured real-time kinetics of peptide binding to empty class II MHC proteins. Our experiments identified an obligate intermediate in the binding reaction. The observed kinetics were consistent with a binding mechanism that involves an initial bimolecular binding step followed by a slow unimolecular conformational change. The same mechanism is observed for different peptide antigens. In addition, we noted a reversible inactivation of the empty MHC protein that competes with productive binding. The implications of this kinetic mechanism for intracellular antigen presentation pathways are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10736175     DOI: 10.1021/bi9923656

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  The kinetic basis of peptide exchange catalysis by HLA-DM.

Authors:  J A Zarutskie; R Busch; Z Zavala-Ruiz; M Rushe; E D Mellins; L J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  High-throughput engineering and analysis of peptide binding to class II MHC.

Authors:  Wei Jiang; Eric T Boder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-09       Impact factor: 11.205

3.  Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.

Authors:  Timo Burster; Henriette Macmillan; Tieying Hou; James Schilling; Phi Truong; Bernhard O Boehm; Fang Zou; Kenneth Lau; Michael Strohman; Steven Schaffert; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

4.  Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association.

Authors:  Gijsbert M Grotenbreg; Melissa J Nicholson; Kevin D Fowler; Kathrin Wilbuer; Leah Octavio; Maxine Yang; Arup K Chakraborty; Hidde L Ploegh; Kai W Wucherpfennig
Journal:  J Biol Chem       Date:  2007-05-24       Impact factor: 5.157

5.  Small molecules that enhance the catalytic efficiency of HLA-DM.

Authors:  Melissa J Nicholson; Babak Moradi; Nilufer P Seth; Xuechao Xing; Gregory D Cuny; Ross L Stein; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

Review 6.  HLA-DM: arbiter conformationis.

Authors:  Andrea Ferrante
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

7.  Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.

Authors:  Liusong Yin; Peter Trenh; Abigail Guce; Marek Wieczorek; Sascha Lange; Jana Sticht; Wei Jiang; Marissa Bylsma; Elizabeth D Mellins; Christian Freund; Lawrence J Stern
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

8.  MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.

Authors:  Mollie M Jurewicz; Richard A Willis; Vasanthi Ramachandiran; John D Altman; Lawrence J Stern
Journal:  Anal Biochem       Date:  2019-06-13       Impact factor: 3.365

9.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

Review 10.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.